Deva Holding is one of the well-established pharmaceutical companies in Turkey that has been operational since 1958. The main area of activity of the company comprises manufacturing and marketing of medicinal products for human use and raw materials, and also the manufacturing of veterinary drugs, eau de cologne and medical ampoules.
"Deva Holding takes fast steps towards achieving its target of being the first choice by creating giant pharmaceutical brands in the fields in which it competes, offering innovative and diversified products with high quality experience so that everybody can access a healthy life on a global level. Offering new products to market every year, Deva Holding makes a difference by enriching its product range," states the corporate website of the firm.
Currently, there are approximately 400 products in its product portfolio in 13 different therapeutic fields from oncology to cardiology, respiratory system to nervous system. With the regional growth operations and export activities increasingly continuing, the holding is registered in over 400 countries including Switzerland, Germany, the Netherlands, and the United Kingdom. It exports pharmaceuticals and pharmaceutical raw materials to over 30 countries including New Zealand.
The company prides itself on a strong staff comprising of trained personnel who have expertise in their field, and laboratory equipped with cutting-edge technology as well as its manufacturing sites. Deva Holding was also was chosen as the company with the best R&D Center in the pharmaceutical Sector by the Ministry of Science, Industry and Technology of Turkey, and with its state-of-the-art the manufacturing facilities has become the local pharmaceutical company with the most comprehensive manufacturing activities in Turkey.
Continuing its manufacturing activities in the manufacturing facilities in Cerkezkoy and Kartepe, Deva Holding has an annual production capacity of 500 million boxes.
LATEST issue 4/2018